US Patent 8361972 Pharmaceutical formulations containing an SGLT2 inhibitor
All edits
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+190 characters)
Article
Patent abstract
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Dilbir S. Bindra0
Jatin M. Patel0
Li Tao0
Mandar V. Dali0
Nipa Vatsaraj0
Prakash V. Parab0
Ravindra W. Tejwani0
Yongmei Wu0
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08361972 Pharmaceutical formulations containing an SGLT2 inhibitor US Patent 8361972 Pharmaceutical formulations containing an SGLT2 inhibitor
Infobox
Patent Number
083619720
Patent Number
83619720
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
083619720
Date of Patent
January 29, 2013
0Patent Application Number
135294630
Date Filed
June 21, 2012
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08361972 Pharmaceutical formulations containing an SGLT2 inhibitor
Infobox
Is a
Patent jurisdiction
Patent number
08361972
Date of patent
January 29, 2013
Patent application number
13529463
Date Filed
June 21, 2012
Patent primary examiner
Find more entities like US Patent 8361972 Pharmaceutical formulations containing an SGLT2 inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.